Iomedico Ag

This study looked at how well the drug tucatinib (Tukysa) works in everyday medical practice for people with advanced HER2-positive breast cancer who had already tried at least two other treatments. Researchers tracked 49 adults in Germany and Austria to see how their quality of …

This study followed 8 adults in Germany with a specific genetic form of acute myeloid leukemia (AML) who could not have standard chemotherapy. They received a combination of two drugs, ivosidenib and azacitidine, to control the disease. The main goal was to measure how treatment …

This study observed 45 people with chronic lymphocytic leukemia (CLL) who were taking the drug acalabrutinib (Calquence) along with a direct oral anticoagulant (DOAC), a type of blood thinner. The main goal was to see how many patients had serious bleeding events while on this co…

This study looked at 10 adults with advanced gastrointestinal stromal tumor (GIST) who had already tried three or more other treatments. Researchers observed how ripretinib affected their quality of life and disease control in real-world German clinics. The goal was to gather pra…

This study looked at how faithfully adults with multiple myeloma (a type of blood cancer) follow their prescribed carfilzomib combination treatments in everyday medical practice. It included 359 patients who had already tried at least one prior therapy. The goal was to measure ad…